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Abstract: As other neurodegenerative diseases, Alzheimer’s disease, the most frequent dementia
in the elderly, is characterized by multiple progressive impairments in the brain structure and
in clinical functions such as cognitive functioning and functional disability. Until recently, these
components were mostly studied independently since no joint model for multivariate longitudinal
data and time to event was available in the statistical community. Yet, these components are
fundamentally inter-related in the degradation process towards dementia and should be analyzed
together. We thus propose a joint model to simultaneously describe the dynamics of multiple
correlated components. Each component, defined as a latent process, is measured by one or sev-
eral continuous markers (not necessarily Gaussian). Rather than considering the associated time
to diagnosis as in standard joint models, we assume diagnosis corresponds to the passing above
a covariate-specific threshold (to be estimated) of a pathological process which is modelled as
a combination of the component-specific latent processes. This definition captures the clinical
complexity of diagnoses such as dementia diagnosis but also benefits from simplifications for
the computation of Maximum Likelihood Estimates. We show that the model and estimation
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2procedure can also handle competing clinical endpoints. The estimation procedure, implemented
in a R package, is validated by simulations and the method is illustrated on a large French
population-based cohort of cerebral aging in which we focused on the dynamics of three clinical
manifestations and the associated risk of dementia and death before dementia.
Keywords: aging; competing risks; dynamic model; joint model; latent process model; multi-
variate longitudinal data
1. Introduction
Dementia is a syndrome which mostly affects individuals 60 years and older, the most frequent
type of dementia (approximately 60%) being Alzheimer’s disease. Dementia is characterized by a
very long degradation process before clinical diagnosis which lasts a few decades (Amieva et al.,
2008). As other neuro-degenerative diseases, the degradation process in dementia has multiple
anatomo-clinical components (Jack et al., 2013) including an accumulation of biomarkers in
the brain (β-amyloid, τ protein), an alteration of the brain structure (atrophy of some regions
such as the hippocampus), impaired clinical manifestations with the decline of several cognitive
functions (e.g., executive functions, processing speed, episodic memory), an increase of functional
limitations in the daily life (e.g. shopping, toileting, transferring from bed to chair), and possibly
increased depressive symptoms among other behavioral alterations. Although inter-related, these
components were mostly studied independently with a large focus on cognitive decline for which
repeated measures have been available for long in cerebral aging cohorts (e.g., Proust-Lima et al.,
2016; Graham et al., 2011).
The limitation to a single component (also called domain thereafter) was partly explained by
the statistical complexity of analyzing multiple longitudinal components in link with a clinical
endpoint. It requires the joint modelling of multivariate longitudinal markers and a survival
3process. A series of joint models for multiple longitudinal and survival data were proposed (see
review in Hickey et al., 2016 and examples in Albert and Shih, 2010; Andrinopoulou et al., 2014;
Baghfalaki et al., 2014; Chi and Ibrahim, 2006; Choi et al., 2014; Lin et al., 2002; Pantazis
et al., 2005) but their application was limited to very simple cases. Indeed numerical complexity
is considerable in joint models involving multiple longitudinal components due notably to an
integral over the random effects in the likelihood which can not be solved analytically. The
integral computation becomes cumbersome with more than a couple of random effects (Albert
and Shih, 2010; Rizopoulos et al., 2009) and not necessarily accurately solved (Ferrer et al., 2016).
This entails that most applications focused on only two longitudinal markers (e.g. Lin et al., 2002;
Li et al., 2012) and/or random intercepts only (Li et al., 2012; Tang and Tang, 2015) which is
not sensible in complex diseases such as dementia. Contributions also mostly relied on a Bayesian
estimation to circumvent the numerical issues (Andrinopoulou et al., 2014; Baghfalaki et al.,
2014; Chi and Ibrahim, 2006; Choi et al., 2014; Tang and Tang, 2015) or a two-stage estimation
(Albert and Shih, 2010).
An additional problem in dementia as in many other diseases (especially in psychiatry and
neurology) is that each domain is not directly measured; it is approached by multivariate markers.
For example, cognitive level is usually measured by a battery of psychometric tests to apprehend
all the coexisting cognitive functions, and brain structure comprises various regional volumes
including the hippocampus volume but not limited to (Dickerson et al., 2009). Joint models
for multivariate longitudinal markers measuring the same underlying process were proposed but
were systematically limited to a univariate latent process (He and Luo, 2016; Luo, 2014) such
as cognition in dementia (Proust-Lima et al., 2016). Finally, for psychometric and behavioral
data at least, the usual assumption of normality does not hold and normalizing transformations
have to be incorporated in the model to be able to rely on standard linear mixed regressions
(Proust-Lima et al., 2011).
4In this context, our work aimed at developing a novel joint model for multivariate longitu-
dinal markers measuring several latent processes and one or several clinical events. Instead of
considering a standard proportional hazard model for the time to event, as mainly done in joint
modelling framework, we considered a degradation process model for each clinical endpoint: the
clinical endpoint is defined as a binary variable repeatedly collected at visits which becomes posi-
tive when its underlying continuous degradation process has passed above an unknown threshold.
Using this definition, clinically relevant for dementia diagnosis and many other clinical endpoints,
the joint model has an exact likelihood. As such, it can be applied to cases with more than just
a couple of longitudinal markers and/or random effects. The replacement of the classical survival
model by another model to provide exact likelihood had already been proposed in joint models
with a univariate longitudinal Gaussian marker (Barrett et al., 2015). In their work, the authors
had opted for a sequential probit model defined in discrete time with which our approach has
some similarities as explained in discussion.
Section 2 describes the joint model for multiple latent domains and one clinical endpoint.
Section 3 details the likelihood computation and Section 4 extends the model to other types of
endpoints and competing endpoints. Section 5 validates by simulations the estimation procedure
which is implemented in a R package. Section 6 details an application to three clinical manifesta-
tions in dementia, cognitive functioning, functional dependency and depressive symptomatology,
in link with dementia diagnosis and in the presence of competing risk of dementia-free death.
Finally, we conclude in Section 7.
2. The joint model for multiple latent domains and a clinical endpoint
The joint model for multiple latent domains and a clinical endpoint is described in Figure 1 and
formalized in Subsections 2.1, 2.2 and 2.3.
52.1 Latent domains measured by multivariate longitudinal markers
In a population of N individuals, let consider D latent domains (e.g., cognition, brain structure),
each one defined for individual i (i = 1, ..., N) as a latent process in continuous time (Λdi (t))
with t ∈ R and d = 1, ..., D. Each latent domain d is measured through a battery of Kd markers
repeatedly collected over time (e.g., several cognitive tests, volumes of different brain regions).
Let define Y dkij the measure of marker k (k = 1, ...Kd) and individual i for domain d collected at
time tdkij with j = 1, ...ndki.
To handle markers that are not necessarily Gaussian, we rely on previous works (Proust-Lima
et al., 2013) and assume that each marker, normalized by a parameterized link function, is a
noisy measure of the underlying latent domain:
Hdk (Y
d
kij ;η
d
k) = Λ
d
i (tdkij) + 
d
kij (2.1)
where dkij are centered independent Gaussian measurement errors with variance σ
d
k
2
and
Hdk (.;η
d
k) is the link function which transforms the marker into a Gaussian framework. This link
function depends on parameters ηdk that are estimated on the data along with the other parame-
ters. Any family of monotonically increasing parameterized transformations can be chosen for Hdk ,
including the family of linear transformations which reduces to the standard Gaussian case. When
departures from normality are suspected, we recommend the flexible and parsimonious family of
linear combinations of quadratic I-splines (ISl) so that H
d
k (x;η
d
k) = η
d
k0 +
∑ndk+1
l=1 η
d
kl
2
ISl(x) with
ndk the number of knots kept small for parsimony (I-splines are integrated M-splines which ensure
the monotonicity of the link functions, see Ramsay, 1988). Previous simulation studies demon-
strated that using such nonlinear parameterized link functions yielded correct inference in mixed
models when marker distribution deviated from normality (Proust-Lima et al., 2011). Note that
although not detailed here for sake of brevity, marker-specific effects of covariates and/or random
effects can be easily added to this equation of observation (Proust-Lima et al., 2013).
62.2 Correlated trajectories of latent domains
Each latent domain trajectory is described via a linear mixed model (Laird and Ware, 1982):
Λdi (t) = Xid(t)
>βd +Zid(t)>bdi + w
d
i (t) ,∀t ∈ R (2.2)
where Xid(t) is a vector of covariates associated with the vector of fixed effects β
d at the
population level andZid(t) is a vector of covariates associated with the qd-vector of random effects
bdi at the individual level with b
d
i ∼ N (0,Bdd). A zero-mean Gaussian process wdi (t) can be added
to make the trajectory more flexible at the individual level; for example a Brownian motion
with covariance structure cov(wdi (t), w
d
i (u)) = σ
2
wdmin(t, u) is often relevant in aging studies
(Proust et al., 2006; Ganiayre et al., 2008). We chose to keep the zero-mean Gaussian processes
independent across domains. The correlation between the latent domains is only captured by
correlations between the domain-specific random effects so that each individual is characterized
by an overall vector of random effects:
bi =

b1i
...
bdi
...
bDi
 ∼ N


0
...
0
...
0
 ,B =

B11 ... B1d ... B1D
...
. . .
...
. . .
...
B>1d ... Bdd ... BdD
...
. . .
...
. . .
...
B>1D ... B
>
dD ... BDD

 (2.3)
where Bde is the covariance matrix between random effects of latent domains d and e ((d, e) ∈
{1, D}2). The unstructured B matrix was parameterized through the q = ∑Dd=1 qd variances of
random effects (parameter σ. to estimate (σ. ∈ R) for a variance of σ.2) and the q × (q − 1)
2
correlations between pairs of random effects (parameter ρ. to estimate (ρ. ∈ R) for a correlation
of
exp(ρ.)− 1
1 + exp(ρ.)
. As in any latent variable model, the dimension (location and scale) of the latent
processes need to be defined to reach identifiability. This is achieved by standardizing each latent
process d with a zero mean intercept in βd and a unit variance of the random intercept in bdi .
72.3 Degradation process toward a clinical endpoint
We assume there exists a degradation process in continuous time for each individual i denoted
(∆diagi (t)) with t ∈ R. This process is measured by repeated observations of the clinical status of
interest, dementia diagnosis in our case, Y diagij at time t
diag
ij with j the occasion (j = 1, ..., n
diag
i )
so that an individual has the positive clinical status if the degradation process with an additional
noise has reached a threshold (to estimate) at the visit time:
Y diagij = 1 ⇔ ∆diagi (tdiagij ) + diagij > ζdiag0 + Xdiagij
>
ζdiag (2.4)
where diagij is a zero-mean Gaussian independent random variable (
diag
ij ∼ N (0, 1)), ζdiag0 is
the threshold parameter in the reference group and Xdiagij is a vector of covariates associated with
parameters ζdiag that can modulate the threshold defining the positive clinical status. Note that
observations are no more considered after a change to a positive clinical status. The variance of
diagij is constrained to 1 to ensure identifiability as shown in supplementary material, Section 1.1.
The degradation process is defined as a linear combination of the latent domains:
∆diagi (t) = γ1iΛ
1
i (t) + ... + γdiΛ
d
i (t) + ... + γDiΛ
D
i (t) (2.5)
where γdi is the intensity of latent domain d contribution for individual i. It can be contrasted
according to covariates with γdi = X
diag
di
>
γd in which X
diag
di is a vector of covariates (includ-
ing the intercept) associated with the vector of parameters γd. For instance, in dementia, the
contributions of latent domains may be modulated by factors linked to cognitive reserve.
3. Maximum Likelihood Estimation
The entire vector of parameters denoted θ comprises parameters {ηdk , d = 1, ..., D, k = 1, ...,Kd},
{βd, σwd , σdk,γd, d = 1, ..., D}, ζdiag0 , ζdiag and all the parameters σ and ρ constituting the B
matrix. It is estimated in the maximum likelihood framework.
83.1 Likelihood
Let denote Y diagi = (Y
diag
ij )j=1,...,ndiagi
the repeated observed diagnoses, Yi = (Y
d
i )d=1,...,D the
repeated and multivariate observed markers (with Y di the vector of all the repeated and mul-
tivariate observations of latent domain d) and Λi =
(
(Λdi (t
diag
ij ))j=1,...,ndiagi
)
d=1,...,D
the set of
latent processes at the observed diagnosis visits. By denoting f(X) the generic probability density
function of a random variable X, the likelihood is L(θ) =
N∏
i=1
f(Y diagi ,Yi;θ) with
f(Y diagi ,Yi) =
∫
RDn
diag
i
f(Y diagi ,Yi|Λi)f(Λi)dΛi =
∫
RDn
diag
i
f(Y diagi |Λi)f(Yi|Λi)f(Λi)dΛi
= f(Yi)
∫
RDn
diag
i
f(Y diagi |Λi)f(Λi|Yi)dΛi
(3.6)
where the vector of parameters θ is omitted for simplicity and
• the marginal density of the repeated markers f(Yi) can be decomposed into the multivari-
ate normal density of the transformed observations of the markers through the link func-
tions φH(Y )(H(Yi);µH(Y ),VH(Y )) times the Jacobian of the link functions J(H(Yi)) =∏D
d=1
∏Kd
k=1
∏ndki
j=1 J(H
d
k (Y
d
kij ;η
d
k)). The multivariate normal density of the transformed ob-
servations H(Y ) has mean µH(Y ) = Xiβ and variance VH(Y ) = ZiBZi
>+Ri+Σi with
β = (βd)d=1,...D, Xi and Zi the D-block diagonal matrices with blocks X
d
i and Z
d
i that
comprise row vectors Xid(t)
>
and Zid(t)
>
for all the outcome-specific occasions t, Ri the
covariance matrix of the Gaussian processes (wdi (t)) at the same visits and Σi the diagonal
variance matrix of measurement errors;
• Following equations (2.4) and (2.5), the conditional distribution of the repeated diagnoses
is defined as follows (detailed calculations are provided in supplementary material, Section
1.2):
– f(Y diagi |Λi) = Φ(n
diag
i )
(
ζi − ΓiΛi; 0, Indiagi
)
for subjects not diagnosed with demen-
tia where Φ(n)(x;m,V ) is a n-dimensional Gaussian cumulative distribution function
9with meanm and variance V computed in x, ζi =
(
ζdiag0 + X
diag
ij
>
ζdiag
)
j=1,...,ndiagi
,
Γi =
(
γ1iIndiagi
... γdiIndiagi
... γDiIndiagi
)
and In is the n×n identity matrix;
– f(Y diagi |Λi) = Φ(n
diag
i −1)
(
ζ−i − Γ−i Λi; 0, Indiagi −1
)
−Φ(ndiagi )
(
ζi − ΓiΛi; 0, Indiagi −1
)
for those diagnosed with dementia; ζ−i and Γ
−
i are respectively ζi and Γi without the
last row for tdiag
indiagi
;
• the conditional density f(Λi|Yi) is a multivariate normal density function φΛi(Λi;µΛi ,VΛi)
with mean µΛi = X˜iβ+VΛH(Y )VH(Y )
−1(H(Yi)−Xiβ) and variance VΛi = Z˜iBZ˜i
>
+
R˜i−VΛH(Y )VH(Y )−1VΛH(Y )> where X˜i and Z˜i are the D-block diagonal matrices with
blocks X˜
d
i and Z˜
d
i that comprise row vectors Xid(t)
>
and Zid(t)
>
at diagnosis visits tdiagij
(j = 1, ..., ndiagi ), R˜i the covariance matrix of the Gaussian processes (w
d
i (t)) at the same
visits and ˜˜Ri the covariance matrix of the Gaussian processes (w
d
i (t)) between diagnosis
visits and marker visits so that VΛH(Y ) = Z˜iBZi
>
+ ˜˜Ri.
The joint density of the observations can thus be rewritten:
f(Y diagi ,Yi) = φH(Y )(H(Yi);µH(Y ),VH(Y ))J(H(Yi)) ×
∫
RDn
diag
i
Φ(n
diag
i )
(
ζi − ΓiΛi; 0, Indiagi
)
φΛi(Λi;µΛi ,VΛi)dΛi if Y
diag
ij = 0 ∀j∫
RDn
diag
i
(
Φ(n
diag
i −1)
(
ζ−i − Γ−i Λi; 0, Indiagi −1
)
−
Φ(n
diag
i )
(
ζi − ΓiΛi; 0, Indiagi
))
φΛi(Λi;µΛi ,VΛi)dΛi if Y
diag
indiag
= 1
(3.7)
Instead of approximating the multivariate integral over Λi by numerical integration techniques
(as mostly done in joint modelling area with Gaussian quadratures), we use the properties of the
skew-normal variables which provide a closed form for the integrals in equation (3.7) (Arnold,
2009) (see Appendix for the general formula). The joint density becomes:
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f(Y diagi ,Yi) = φH(Y )(H(Yi);µH(Y ),VH(Y ))J(H(Yi)) ×
Φ(n
diag
i )
(
ζi − ΓiµΛi ; 0, Indiagi + ΓiVΛiΓi
>
)
if Y diagij = 0 ∀j
Φ(n
diag
i −1)
(
ζ−i − Γ−i µΛi ; 0, Indiagi −1 + Γ
−
i VΛiΓ
−
i
>)−
Φ(n
diag
i )
(
ζi − ΓiµΛi ; 0, Indiagi + ΓiVΛiΓi
>
)
if Y diag
indiag
= 1
(3.8)
3.2 Likelihood accounting for delayed entry
When necessary, delayed entry can be accounted for by dividing the likelihood by the probability
of being at risk of the clinical endpoint at study entry that is Y diagi1 = 0 at time t
diag
i1 :
Ldelayed(θ) =
L(θ)∏N
i=1 P (Y
diag
i1 = 0)
(3.9)
where
P (Y diagi1 = 0) =
∫
RD
Φ(1)
(
ζ0i − Γ0iΛ0i ; 0, 1
)
φ(Λ0i ;X
0
i β,Z
0
iBZ
0
i
>
+R0i )dΛ
0
i
= Φ(1)
(
ζ0i − Γ0iX0i β; 0; 1 + Γ0i (Z0iBZ0i
>
+R0i )Γ
0
i
>) (3.10)
with Λ0i = (Λ
d
i (t
diag
i1 ))d=1,...,D the latent processes at entry, ζ
0
i = ζ
diag
0 + X
diag
i1
>
ζdiag the
threshold at entry, Γ0i = (γ1i, ..., γDi) the vector of domain-specific contributions, X
0
i and Z
0
i
the D-block diagonal matrices with blocks Xdi (t
diag
i1 ) and Z
d
i (t
diag
i1 ), and R
0
i the variance of the
Gaussian processes at entry wdi (t
diag
i1 ) for d = 1, ..., D.
3.3 Likelihood Optimization and implementation
The log-likelihood is maximised using a modified Marquardt algorithm, a Newton-like algorithm,
with convergence criteria based on parameter and log-likelihood stability and derivatives size
(Proust-Lima et al., 2017). The latter is defined at iteration l as ∇(L(θ
(l)))>H(l)−1∇(L(θ(l)))
nθ
6 ω
with ∇(L(θ(l))) and H(l) the gradient and the Hessian matrix of the log-likelihood at iteration
l, nθ the length of θ, and ω the convergence threshold (fixed here at 0.001). This criterion is
very stringent and ensures convergence toward a maximum. The program was implemented in
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C++ with an interface in R and parallel computations to fasten the estimation procedure. The R
package called multLPM can be downloaded on github: (https://github.com/VivianePhilipps/
multLPM). The program fits any model that has the same structure as defined in Section 2 (and
possibly a second competing event as defined in Section 4). The multivariate normal cumulative
distribution functions were computed by using Genz routines (Genz, 1992).
4. Extension to multiple clinical endpoints and continuous-time events
4.1 Multiple endpoints at predefined visits
The definition of the degradation process and measurement model for a clinical event observed
at specific visits such as diagnoses (Subsection 2.3) extends naturally to the case of two causes
of diagnosis (with cause-specific degradation processes). The log-likelihood has the exact same
structure except that the dimension of the cumulative distribution functions is augmented to the
number of visits for each cause of clinical event, 2 × ndiagi if the two diagnoses are made at the
same times.
4.2 Event in continuous time
The model definition relies on discrete repeated visits for the clinical event and as such does not
directly extend to clinical events that are intrinsically defined in continuous time such as death.
With events in continuous time, a preliminary discretization of time is necessary: we partition
time into S intervals Is = [ls, us] with midpoints ms for s = 1, ..., S (ls = us−1 for s > 1). A
subject is followed from interval s0i, the interval containing the exact entry time in the study,
and is followed until interval si: if the subject has the event, si is such that the time of event
is in Isi ; if the subject is censored, si is such that the censoring time is in Isi+1. Without loss
of generality, we focus on death and define the repeated death status Y deathij in each interval j
(j = s0i, ..., si) with Y
death
ij = 0 for all j except j = si for those who die (Y
death
isi
= 1).
12
Using the exact same definition as for clinical diagnoses, we consider a latent degradation
process defined as a linear combination of the latent domains:
∆deathi (t) = δ1iΛ
1
i (t) + ... + δdiΛ
d
i (t) + ... + δDiΛ
D
i (t) (4.11)
We then define the probability of dying in interval s as the probability that the noisy under-
lying degradation process is above a specific threshold at the midpoint of interval s:
P (Y deathis = 1) = P (∆
death
i (ms) + 
death
is > ζdeath0 + Xdeathis
>
ζdeath) (4.12)
As previously, δdi characterizes the intensity of latent domain d contribution for individual i and
it can be contrasted according to covariates with δdi = X
death
di
>
δd in which X
death
di is a vector
of covariates (including the intercept) associated with the vector of parameters δd; 
death
is is a
zero-mean Gaussian independent random variable (deathis ∼ N (0, 1)); ζdeath0 is the threshold in
the reference group and Xdeathis is a vector of covariates associated with parameters ζ
death that
can modulate the threshold defining the death status. In particular, Xdeathis may include time.
When this discretized event replaces clinical diagnosis, the likelihood has the same structure
except that the dimension of the cumulative distribution function becomes si − s0i + 1. In case
of delayed entry, the likelihood is divided by the probability to have survived until ls0i .
4.3 Endpoint at predefined visits in competition with an event in continuous time
Without loss of generality, we take the example of a clinical diagnosis for which death before
diagnosis constitutes a competing event. The methodology handles this by combining the two
degradation processes of sections 2.3 and 4.2, and by slightly changing the observations for death.
To focus on death before diagnosis, we only consider death in the x years following a negative
diagnosis (x=3 years is realistic in the case of dementia). Otherwise, time to death is censored
at the last visit tdiag
indiagi
. With these changes, the joint log-likelihood has again the exact same
structure as in section 3.1 except that the dimension of the cumulative distribution functions
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is augmented to the number of visits for the clinical event and the number of intervals for the
discretized event ndiagi + si − s0i + 1. In case of delayed entry, the likelihood is divided by the
probability to have survived until s0i − 1 and still be at risk of clinical event at entry.
5. Numerical evaluation of the methodology
We evaluated the methodolgy with two series of simulations. We first validated the estimation pro-
cedure under a correctly specified model by investigating different combinations of key simulation
parameters (i.e., number of subjects, proportion of events, nature of the event and uncertainty in
the markers measurement). We then evaluated the behavior of the method under different types
misspecification (i.e., distribution of errors in the degradation model, correlation between the
latent domains, second clinical endpoint or additional domain not modelled). For all scenarios,
design and parameter values were inspired by the application data, and 200 replications were
done. All the scenarios are summarized in supplementary Table S1.
5.1 Simulation study I: Validation of the estimation procedure
We considered two longitudinal domains, namely cognition and functional dependency, measured
by two psychometric tests and one scale, respectively. We generated linear trajectories of the two
domains according to age and adjusted for binary educational level (0.5-probability Bernoulli)
and their interaction for domain 1. Correlated random intercept and slope with age took into
account the correlation within and between domains at the individual level. Entry in the cohort
was generated from a normal distribution (mean 75, standard deviation 3). Observed visits were
generated with a uniform distribution in [-1,1] years around the theoretical visits every 2.5 years
up to 20 years, and a 15% dropout was considered at each visit. We primarily considered that the
two domains contributed to the clinical event model and that a clinical diagnosis was made at
each visit. Longitudinal data were censored after the event. We considered Gaussian longitudinal
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markers with different ranges inspired by psychometric tests IST and DSST for cognition and
IADL sum-score for function (see application Section 6). More details on the generating procedure
are given in supplementary section 2.1.
In the main scenario (I.1.a), generating parameters roughly corresponded to those obtained on
the application data and samples included 500 subjects. Over 200 replicates, this lead on average
to 4.3 visits per subject and 150 diagnoses (30%). As reported in Table 1, parameters were
well estimated without bias and no departure from the expected 95% coverage rate of the 95%
confidence interval. In additional simulations, we also considered: (scenario I.1.b) smaller samples
of 200 subjects which lead in mean to 59 (29.5%) diagnoses; (scenarios I.2.a and I.2.b) smaller
proportion of diagnoses by changing the values of each domain contribution. This lead on average
to 56 (11%) and 22 (11%) diagnoses in samples of 500 and 200 subjects, respectively; (scenario
I.3) larger measurement errors for the markers; (scenario I.4) continuous event discretized into
10 intervals instead of a clinical diagnosis made at each visit. In all these scenarios, inference
remained correct with negligible bias and satisfying coverate rates (see supplementary Tables S2
to S6). With 200 subjects, variances were systematically higher though. Overall, these simulations
validated the estimation procedure.
5.2 Second simulation study: Behavior under misspecification
Based on the same overall design of simulations, we investigated 4 types of misspecification. Re-
sults are summarized in supplementary material, section 2. When generating logistic errors in
the degradation process toward diagnosis (in equation (2.4)) instead of Gaussian errors (supple-
mentary Table S7) or when neglecting the intra-individual correlation between latent domains
(supplementary Table S8), inference quality was not much affected. When a second event was not
modelled (supplementary Table S9), results depended on the level of association between domains
and neglected competing event. Inference was not affected with very small contributions of the
15
Table 1: Simulation results for 2 longitudinal domains and diagnosis of dementia on 200 replicates
of 500 subjects (Scenario I.1.a - 194 models converged in less than 30 iterations). θ refers to the
generated value and θˆ to the mean estimate over the replicates. The bias is reported relative to
the expected value in %. SD(θˆ) refers to the empirical standard deviation of the estimates, ŜE(θˆ)
refers to the mean standard error of the estimates, and 95%CR refers to the coverage rate of the
95% confidence interval of the estimate.
Parameter θ θˆ bias (%) ŜE(θˆ) SD(θˆ) 95%CR
Model for Domain 1 (markers m1 and m2)
Intercept∗ 0 0 - - - -
age 1.000 1.004 0.4 0.066 0.061 94.8
EL -1.100 -1.105 0.4 0.118 0.122 94.3
age×EL 0.100 0.102 1.9 0.058 0.057 94.3
Transformation parameter 1 (m1) 18.000 17.996 <0.1 0.323 0.329 94.3
Transformation parameter 2 (m1) 4.000 3.985 0.4 0.189 0.194 93.3
SD of error (m1) 0.800 0.805 0.6 0.041 0.042 94.8
Transformation parameter 1 (m2) 20.000 20.004 <0.1 0.390 0.397 95.9
Transformation parameter 2 (m2) 5.000 4.979 0.4 0.226 0.226 94.8
SD of error (m2) 0.300 0.302 0.5 0.015 0.015 95.9
Model for Domain 2 (marker m3)
Intercept∗ 0 0 - - - -
Age 1.700 1.730 1.8 0.205 0.202 96.9
EL -0.500 -0.510 2.0 0.123 0.127 95.4
Transformation parameter 1 (m3) 5.000 5.001 <0.1 0.010 0.010 97.9
Transformation parameter 2 (m3) 0.100 0.099 0.9 0.011 0.010 97.4
SD of error (m3) 0.900 0.914 1.6 0.106 0.104 96.4
Variance Covariance matrix of random effects for Domain 1 (d1) and Domain 2 (d2)
SD intercept (d1)∗ 1 1 - - - -
SD slope (d1) 0.513 0.515 0.5 0.032 0.031 95.4
SD intercept (d2)∗ 1 1 - - - -
SD slope (d2) 0.883 0.891 0.9 0.086 0.090 95.4
Corr† intercept (d1) and slope (d1) -0.833 -0.829 0.5 0.137 0.140 94.3
Corr† intercept (d2) and slope (d2) -1.070 -1.048 2.1 0.232 0.225 95.9
Corr† intercept (d1) and intercept (d2) 0.905 0.936 3.4 0.223 0.231 97.9
Corr† slope (d1) and intercept (d2) -0.956 -0.970 1.4 0.253 0.262 98.5
Corr† intercept (d1) and slope (d2) -0.297 -0.308 3.6 0.173 0.173 95.9
Corr† slope (d1) slope (d2) 1.899 1.952 2.8 0.265 0.259 95.9
Model for the clinical endpoint
Threshold 3.000 3.021 0.7 0.180 0.178 96.9
Contribution of domain 1 0.300 0.302 0.5 0.061 0.065 92.8
Contribution of domain 2 0.400 0.402 0.4 0.066 0.064 96.4
∗ fixed parameter; † transformed correlation parameter
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domains but as expected, parameters of the degradation process model became slightly biased
with increased contributions (as it lead to informative censoring). When a third correlated latent
domain was not modelled, the inference at the latent domain (and marker) level remained correct.
The estimates of the degradation process differed depending on the intensity of association with
the neglected domain but this was expected as the interpretation of the contributions (adjusted
or not for other domains) differ (supplementary Table S10).
6. Application to clinical manifestations in dementia
Changes in various clinical measures such as cognitive tests, dependency scales or depressive
symptomatology have been separately observed in prodromal dementia (Amieva et al., 2008)
suggesting a possible concomitant role in the dementia process with a modulation of the intensity
by educational level which illustrates a potential compensatory mechanism. Our objective was
to precisely investigate the role of cognition, dependency and depression in the degradation
process toward dementia by jointly analyzing their trajectories and their determinants in link
with dementia diagnosis and accounting for the competing death.
6.1 The PAQUID data
We relied on the data from the population-based PAQUID cohort which included 3777 individuals
aged 65 years and older and living at home in southwestern France in 1989-1990. Individuals
were then followed for up to 25 years with repeated neuropsychological evaluations and clinical
diagnoses of dementia every 2 or 3 years (Letenneur et al., 1994) and death continuously recorded.
We focused on a subsample of 646 individuals who were tested for ApoE4, the main genetic factor
associated with aging. We excluded 22 individuals diagnosed with dementia at baseline and 31
individuals who did not have at least one observation of each clinical measure. The final sample
consisted of 593 individuals among which 180 developed a dementia and 283 died in the three
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years following a negative dementia diagnosis. The sample comprised 332 (56%) women, 438
(74%) individuals with higher education level (EL+; individuals who graduated from primary
school) and 130 (22%) carriers of at least one copy of the APOE4 allele. The mean age at entry
was 73.6 (SD=6.1) years.
The three clinical manifestations were:
• Cognitive impairment ; it was assessed by four psychometric tests (inverted so that higher
levels indicated higher impairment). The Mini-Mental State Examination (MMSE) provides
an index of global cognitive performance, the Benton Visual Retention Test (BVRT) assesses
visual memory, the Isaacs Set Test (IST) measures verbal semantic memory and speed,
and the Digit Symbol Substitution Test (DSST) provides a global measure of executive
functioning and processing speed.
• Functional dependency ; it was assessed by the French version of the Instrumental Activities
of Daily Living (IADL). We summed the grades of dependency for four activities, telephone
use, transportation, medication and domestic finances.
• Depressive symptomatology ; it was assessed by the sum-score of the Center for Epidemio-
logic Studies Depression Scale (CES-D).
Individuals had between 1 and 12 repeated measures of each marker with a median of 6
(Interquartile range IQR=4-8) for MMSE, IADL and dementia diagnosis, 5 (IQR=4-8) for CES-
D, 5 (IQR=3-8) for BVRT, 4 (IQR=3-7) for IST and 4 (IQR=2-6) for DSST.
6.2 Model specification
The structure of the model is summarized in Figure 2 and specifics are given below.
Quadratic trajectories according to age were assumed for each domain with an adjustment
for age at entry, EL+, ApoE4 and gender (and their interactions with age and age squared),
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and three individual random effects (on intercept, slope and slope squared) correlated within and
between domains. An additional time dependent variable indicating the baseline evaluation was
included due to evidence of a primo passation negative effect. The selection of covariates and
interactions was determined in separate analyses by domain with a 20% significance level.
Marker-specific link functions used in equation (2.1) to normalize the markers were quadratic
I-splines functions with 3 internal knots placed at the quartiles of the marker distribution over
follow-ups. The relevance of the splines transformations was checked in domain-specific analyses
by comparing the Akaike criterion (AIC) with the AIC of the model assuming a linear link.
Degradation process toward dementia was modelled according to the three domains with an
adjustment for age at entry, gender, ApoE4 carriers and EL+ and a potential change in the
threshold of dementia after the 10-year follow-up visit (due to a new drug on the market that
implied earlier diagnoses).
Degradation process toward dementia-free death was also modelled according to the three
domains. We discretized death into 8 intervals with boundaries at 65, 70, 74, 77, 80, 83, 86, 90
and 104 years chosen according to the distribution of death times. The threshold defining the
probability of dying was modelled according to age using natural cubic B-splines with knots at
70, 83, 90 and 100 years.
As for any complex model, we recommend to estimate the model progressively by first fitting
domain-specific mixed models separately then jointly and finally with dementia and death models.
This provides at each step reasonable initial values and reduces computational time.
6.3 Results
Fixed effects of the multivariate mixed model for cognition, functional dependency and depres-
sive symptoms are given in Table 2 and predicted trajectories by covariate profile are displayed
in Figure S1 of Supplementary Materials. In summary, each domain had a quadratic trajectory
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with age characterized by an acceleration in older ages. Individuals included at an older age were
systematically more impaired than those included at an younger age (whatever the current age)
highlighting a cohort effect. The first passing indicator confirmed that evaluations at baseline
underestimated cognitive level and depressive symptoms while overestimating functional depen-
dency. More educated individuals had better cognitive and functional levels. ApoE4 carriers had
a faster increase of cognitive and functional impairments. Finally, men had a lower level of de-
pressive symptoms at 65 years but the difference with women reduced when age increased. Men
also had a slower increase of functional dependency.
Estimates of the submodel for the degradation process toward dementia are given in Table 3.
Adjusted for covariates, cognitive and functional domains significantly contributed to the degrada-
tion process toward dementia with increased impairments associated to higher degradation of the
dementia process and a higher weight of function among ApoE4 carriers. Interestingly, depressive
symptoms did not contribute at all to the degradation process toward dementia among individ-
uals with a high educational level (θ=-0.447+0.452=0.005, p=0.957), but it highly contributed
among those with a low educational level (θ=-0.447, p=002); in this group, higher depressive
symptoms induced a lower level of the degradation process for the same level of cognition and
function. This result may be explained by the cognitive reserve linked with education. Among
individuals who did not reach a sufficient educational level, having higher depressive symptoms
alters the cognitive evaluation while individuals who reached a sufficient educational level are
able to compensate and properly pass the cognitive evaluation. Finally, the threshold at which
dementia is diagnosed differed according to covariates, with dementia diagnosed at a lower level
of degradation for those with a higher educational level, a younger age or a diagnosis made after
the 10year visit. No significant difference was found according to gender or ApoE4 status.
To illustrate these differences in the structure of the degradation process, Figure 3 displays
the mean predicted trajectories of the degradation process according to education, age at entry
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and ApoE4 status. Note that here, the degradation process was recentered by absorbing the
covariate-specific threshold so that dementia is diagnosed when the process is above 0. ApoE4
status constitutes the main modulating factor of the trajectory toward dementia with ApoE4
carriers diagnosed with a dementia 5 to 6 years before ApoE4 non carriers. In contrast, despite
a different structure of the degradation process according to education, very limited differences
were found which highlights that the differential contribution of depressive symptoms mainly
served as a compensating factor in the degradation process definition.
We investigated the added value of simultaneously considering multiple domains in associa-
tion with dementia and death rather than considering each domain separately. As longitudinal
information differed, we focused on information criteria for dementia and death conditional to
longitudinal information with conditional Akaike and Bayesian Information Criteria (AIC, BIC)
(Zhang et al., 2014) and Universal Approximate Cross Validation criterion (UACV) (Commenges
et al., 2015) (See calculations in supplementary Section 3.1). All criteria concluded to the large
superiority of the multivariate model over univariate models with a difference of at least 0.1 in
UACV, 130 points in AIC and 109 points in BIC (Table 3). From an epidemiologic perspective,
conclusions also differed. In univariate models, each domain contributed positively to the degrada-
tion process toward dementia even depressive symptomatology although, adjusted for cognition
and function, depression was no more positively associated with the degradation process but
contributed only among low educated people and negatively as a compensatory factor.
6.4 Supplementary results and analyses
The estimated splines transformations linking each marker to its underlying domain (Figure S2
in Supplementary Materials) exhibited clear nonlinear relationships except for IST and BVRT
cognitive tests. This illustrates the varying sensitivity to change of scales observed in previous
works (Proust-Lima et al., 2011) and the relevance of taking such nonlinear relationships into
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account. The correlation matrix between the 9 individual random effects also exhibited very high
correlations between the level at 65 years, age and age2 within and between cognitive, functional
and depression domains with correlations up to 0.90 between slopes of cognitive and functional
domains (Figure S3 in Supplementary Materials). In a secondary analysis, we considered the
domains as independent. Although epidemiological results regarding the degradation processes
toward death and dementia did not change, the fit of dementia and death data was substantially
impacted (conditional AIC=2021.0, conditional BIC=2099.9, UACV=1.710).
The goodness-of-fit of the model was check by verifying that the individual predictions were
closed enough to the observations in the multivariate mixed submodel (Figure S4 in Supplemen-
tary Materials). We also verified that the model for dementia-free death considering thresholds
approximated by splines was flexible enough by comparing it with a model considering interval-
specific probability of death (Figure S5 in Supplementary Materials).
7. Discussion
We proposed a novel joint model for multiple longitudinal dimensions and clinical endpoints. Ini-
tially motived by the study of one repeated binary clinical endpoint measured at predefined visits,
the model also applies to continuous endpoints such as death (provided they can be discretized)
and to competing risk setting as shown in the application.
The complexity in joint models, as induced for instance by multiple longitudinal markers,
usually orientates the model development toward Bayesian approaches which may better tackle
numerical problems. An originality of this work is that the estimation in the frequentist frame-
work was made possible thanks to properties of skew-normal distributions which avoided the
cumbersome multiple numerical integration over the random effects usually encountered in joint
shared random effect models (Rizopoulos et al., 2009). As such, this approach can be applied to
contexts where the number of random effects becomes substantial (such as 9 in the application)
and/or correlated Gaussian processes are added to relax the model. Being able to jointly model
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a substantial number of markers becomes indeed a real challenge with the growing availability of
dynamic markers in longitudinal health studies.
The properties of skew-normal distributions had already been exploited to simplify inference
in joint models in the case of a single repeated biomarker and a single continuous time to event
(Barrett et al., 2015). The authors had opted for a sequential probit model for the discretized
time where we opted for a degradation process model (Section 4.2). Although different in their
definition, the two approaches are numerically equivalent in the absence of delayed entry as shown
in Section 1.3 of Supplementary Materials.
In Alzheimer’s disease, this model gives for the first time an opportunity to describe the
multidimensional pathological process toward dementia. We considered cognitive, functional and
depressive symptomatology measures to understand how they contributed to the degradation
process toward dementia. Taken independently, each component was associated with the degra-
dation toward dementia. However, when considered jointly, we found an interesting compensatory
mechanism of depressive symptomatology among lower educated participants. Depressive symp-
tomatology seems to counterbalance their cognitive evaluation which does not correctly translate
their actual cognitive level in the case of depressive symptomatology, probably due to a poorer
cognitive reserve. This mechanism impacted only the definition of the dementia degradation pro-
cess, not its level. We also confirmed and quantified the higher propensity of ApoE4 carriers to
develop dementia. Next step will be to also consider neurodegeneration information to capture
the anatomic component of dementia (Jack et al., 2013).
The approach however has several limits. Although elegant, the technique is limited to man-
ageable dimensions of repeated clinical endpoints at the individual level. The likelihood calcula-
tion relies on algorithms to compute the multivariate normal cumulative distribution function.
Their good precision may become questionable beyond very large dimensions which probably
limits the methodology to no more than two competing events. Such limitation remains at the
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individual level, not at the population level which may still include a lot more intervals and/or
diagnosis visits. In addition, we believe this is a reasonable concession in many applications where
multivariate longitudinal dimensions with a large amount of random effects are to be modelled
and could not by using the numerical approaches previously proposed in the literature. Another
limitation is that the methodology does not apply to repeated binary, ordinal or count markers.
However, by using parameterized link functions, we can handle continuous non Gaussian markers
which permits to correctly analyze many asymmetric scales (Proust-Lima et al., 2011). For the
latent process models, we chose to assume that one marker was the manifestation of only one
latent process as usual in latent variable methodology and that the possible correlation between
the markers was handled at the latent processes level. This was relevant in Alzheimer’s disease
where domains under study are defined from distinct families of markers. However, an interesting
alternative may be to consider independent principal latent processes built from all the markers
in the spirit of principal component analyses. Finally, to adapt to the context of Alzheimer’s
disease, we defined latent processes measured by multiple markers which may not be necessary in
other contexts where markers directly constitute the components under study. The methodology
and the program made available under R apply in such a case as the standard multivariate linear
mixed model constitutes a specific case of the approach.
To conclude, by handling multivariate repeated markers and clinical endpoint, this joint model
opens to many applications in which identifying markers of clinical progression are of importance.
The definition of the clinical endpoint differs from most joint model proposals but it is actually
clinically relevant in many diseases characterized, as in neurodegenerative diseases, by a body of
progressive impairments.
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APPENDIX
We used the following equality obtained by Arnold (2009) (equation 59 of the paper) for skew-
normal variables to compute an exact formula of the joint model likelihood:
Φ(m)
(
λ0; 0,∆ + ΛΛ
T
)
=
∫
Rk
Φ(m) (λ0 + Λz; 0,∆)φ
(k)(z)dz (A.1)
where λ0 is a m-vector, ∆ is a m × m variance covariance matrix and Λ is a m × k matrix.
As in the main text, Φ(n)(x;m,V ) denotes the n-dimensional Gaussian cumulative distribution
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function with mean m and variance V computed in x, and φ(k) is the k-dimensional standard
Gaussian density function.
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Figure 2: Graph representing the joint model applied to PAQUID data with 3 latent domains,
cognition, function and depression, measured respectively by MMSE, IST, BVRT and DSST
cognitive scores, IADL functional scale and CES-D scale of depressive symptoms. Latent do-
mains define two global degradation processes toward dementia and death before dementia. For
simplicity, subscript i for individual i is omitted.
32 REFERENCES
Table 2: Fixed effect estimates of multivariate mixed submodel on PAQUID data (N=593) with
three domains (cognition, functional dependency and depressive symptoms).
Cognition Functional dependency Depressive symptoms
Covariate θ SE p-value‡ θ SE p-value θ SE p-value
Intercept∗ 0 - - 0 - - 0 - -
Age † -0.306 0.141 0.030 -1.371 0.323 <0.001 0.189 0.162 0.244
Age2 † 0.488 0.066 <0.001 1.162 0.186 <0.001 0.053 0.053 0.322
Test for (Age, Age2) <0.001 <0.001 <0.001
Initial age † 0.372 0.102 <0.001 0.211 0.160 0.188 -0.173 0.075 0.021
First passing effect 0.184 0.035 <0.001 -0.257 0.071 <0.001 0.506 0.065 <0.001
EL+ -1.543 0.196 <0.001 -0.614 0.160 <0.001
EL+ × Age 0.010 0.101 0.922
EL+ × Age2 0.044 0.041 0.282
Test for EL+ × (Age, Age2) 0.182
ApoE4+ -0.136 0.156 0.385 -0.030 0.260 0.908
ApoE4+ × Age 0.221 0.214 0.303 -0.554 0.462 0.230
ApoE4+ × Age2 0.063 0.085 0.462 0.494 0.186 0.008
Test for ApoE4+ × (Age, Age2) <0.001 <0.001
Male 0.076 0.194 0.694 -0.859 0.176 <0.001
Male × Age -0.184 0.320 0.565 0.108 0.216 0.616
Male × Age2 -0.045 0.114 0.695 0.051 0.072 0.476
Test for Male × (Age, Age2) 0.038 <0.001
∗ fixed parameter; † Age and Initial age are indicated in decades and centered around 65 years
old; ‡ p-value of the univariate Wald test (or bivariate for italic lines);
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Table 3: Fixed effect estimates of degradation process submodels for dementia and dementia-
free death on PAQUID data (N=593) defined either as a combination of the three domains
(cognition, functional dependency and depressive symptoms) (left panel) or from a single domain
in separated univariate models (righ panels). Are also reported conditional information criteria for
dementia and death data conditional on longitudinal information (conditional AIC, conditional
BIC, UACV).
Three domains Single domain
simultaneously Cognition Dependency Dep. symptoms
Covariate θ SE p θ SE p θ SE p θ SE p
Degradation process toward dementia
Threshold Intercept 2.744 0.268 <0.001 2.885 0.239 <0.001 2.706 0.066 <0.001 2.515 0.074 <0.001
EL+ -0.285 0.156 0.067 -0.642 0.131 <0.001 0.016 0.100 0.873 0.285 0.096 0.003
ApoE4+ -0.008 0.151 0.957 -0.344 0.118 0.003 -0.088 0.209 0.674 -0.345 0.092 <0.001
Male 0.056 0.133 0.674 0.176 0.108 0.102 -0.129 0.103 0.212 0.029 0.090 0.750
Init. age∗ 0.198 0.119 0.097 0.008 0.011 0.486 -0.010 0.009 0.245 -0.062 0.006 <0.001
10y visit -0.418 0.134 0.002 -0.605 0.125 <0.001 -0.556 0.103 <0.001 -0.972 0.082 <0.001
Cognition Intercept 0.511 0.086 <0.001 0.706 0.064 <0.001
Dependency Intercept 0.273 0.060 <0.001 0.313 0.066 <0.001
ApoE4+ 0.136 0.069 0.048 0.097 0.062 0.119
Dep. Sympt. Intercept -0.447 0.147 0.002 0.036 0.089 0.687
EL+ 0.452 0.160 0.005 0.246 0.108 0.023
Degradation process toward death before dementia
Threshold Intercept 1.744 0.108 <0.001 1.725 0.105 <0.001 1.743 0.101 <0.001 1.810 0.099 <0.001
S1(age)† -0.956 0.201 <0.001 -1.204 0.206 <0.001 -1.002 0.199 <0.001 -1.335 0.186 <0.001
S2(age)† -3.125 0.363 <0.001 -3.402 0.503 <0.001 -3.169 0.354 <0.001 -3.697 0.347 <0.001
S3(age)† -4.150 0.414 <0.001 -4.440 0.626 <0.001 -4.233 0.411 <0.001 -4.672 0.404 <0.001
Cognition Intercept -0.011 0.042 0.801 0.079 0.031 0.011
Dependency Intercept 0.178 0.045 <0.001 0.108 0.032 0.001
Dep. Sympt. Intercept -0.105 0.059 0.076 0.010 0.046 0.828
conditional AIC‡ 2021.0 2155.6 2161.2 2438.1
conditional BIC‡ 2099.9 2208.2 2218.3 2495.1
UACV‡ 1.710 1.825 1.824 2.055
∗ Initial age is indicated in decades and centered around 65 years old.
† S1, S2, S3 are natural cubic spline functions applied on age
‡ The lower the better. Are reported Akaike and Bayesian Information Criteria (AIC, BIC) and
Universal Approximate Cross Validation criterion (UACV) for dementia and death data
conditional on longitudinal information. UACV differences of order 10−1 , 10−2 and 10−3
qualified as ”large”, ”moderate” and ”small”, respectively (Commenges et al., 2015).
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Figure 3: Predicted degradation process toward dementia according to education level (EL+ top
panel; EL- bottom panel), Initial age (65y left, 75y middle, 85y right) and ApoE4 status (non
carrier in black, carrier in grey) with 95% confidence bands computed by Monte Carlo (with 2000
draws). The degradation process was recentered so that 0 represents the threshold above which
dementia diagnosis becomes positive for each profile.
